Lowenstein Sandler represented PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma, applied and food markets, in the acquisition of Project Farma, a subsidiary of Precision for Medicine.
Project Farma is a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, offering project management, project controls, commissioning, qualification and validation, quality compliance and engineering consulting services.
The Lowenstein team included David L. Goret, Michael J. Reinhardt, Lauren E. Vanderdrift, Nicola E. Perzichilli, Bryan Sterba, Megan Monson, Sophia Mokotoff, Eric Jesse, Craig Dashiell, Nicholas G. Mehler, Amy C. Schwind, Mark S. Heinzelmann, James C. Shehan, Manali Joglekar, Jessica I. Kriegsfeld, Amani Taha, Chloe Rippe, and Hannah Pastore.
